| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |